Latest News

GLP-1 Breakthroughs and Dr. Coy’s Sugars Are Two Sides of the Same Coin
A recent article published by MDLinx has neurologists abuzz: GLP-1 receptor agonists—originally developed to manage type 2 diabetes and obesity—are showing significant promise in reducing the risk and progression of Alzheimer’s disease. These findings add to a growing...
GLP-1 Breakthroughs and Dr. Coy’s Sugars Are Two Sides of the Same Coin
As new research shows GLP-1 drugs may slow Alzheimer’s progression by improving sugar metabolism and reducing inflammation, it’s clear that brain health starts with metabolic health. But while GLP-1 receptor agonists treat existing imbalances, Dr. Coy’s sugars—like galactose, isomaltulose, and tagatose—prevent them by supporting stable blood sugar and lowering dietary inflammation.
Understanding the Impact of Sucralose on Gut Health and Metabolism
Sucralose is a chemical sweetener made by adding chlorine atoms to regular table sugar. The artificial sweetener isn’t recognised, or processed, by the body, so it has a zero-calorie content.
Empowering Women with Cancer: An Interview with Caroline Justich, Founder of Be accepted
Inspirational and cancer-defying, Caroline Justich is the founder of Be accepted, Home of the smart 8, an initiative for women diagnosed with cancer. Founded in cooperation with the European Society of Radiology, the program offers a magazine and online platform focused on building a bridge between western medicine and complementary evidence-based methods to support therapy, life quality and recovery.
Glucose, Growth and Stress
For the first time Ramon Spectroscopy is allowing scientists to see inside cells and quantify exactly where energy is being used. This revolutionary technique is revealing exactly how glucose is fueling cancer growth in multiple ways.
Cancer Initiation
A remarkable new study published in the British Journal of Cancer has shown that excess glucose in the blood (known as hyperglycemia) reprograms cellular energy pathways, and changes their genetic regulation. Scientists were able to clearly demonstrate how cancerous cells are enabled by elevated glucose levels, allowing them to spread round the body and grow into more dangerous types of tumor.
Metabolic Reprogramming
A remarkable new study published in the British Journal of Cancer has shown that excess glucose in the blood (known as hyperglycemia) reprograms cellular energy pathways, and changes their genetic regulation. Scientists were able to clearly demonstrate how cancerous cells are enabled by elevated glucose levels, allowing them to spread round the body and grow into more dangerous types of tumor.
The Warburg Effect: Diet and Cancer (the latest evidence)
In 1931 Otto Warburg won a Nobel Prize for his research into tumours, and cancer cells. He discovered that healthy cells and cancer cells ‘breathe and eat’ (metabolise) very differently. Ever since his ground-breaking discovery over 90 years ago, scientists have been researching these critical metabolic differences. Thousands of scientific papers have been published to understand why, and how, cancer cells rewire their metabolism.